Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability-Reference-Cited by-同舟云学术

Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability

Published:2006-10-25 Issue:3 Volume:104 Page:257-266
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Lovelock Paul K.,Wong Ee Ming,Sprung Carl N.,Marsh Anna,Hobson Karen,French Juliet D.,Southey Melissa,Sculley Tom,Pandeya Nirmala,Brown Melissa A.,Chenevix-Trench Georgia,Spurdle Amanda B.,McKay Michael J.,

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9415-5.pdf

Reference42 articles.

1. Sakayori M, Kawahara M, Shiraishi K et al (2003) Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2 genes in familial breast cancer. J Hum Genet 48(3):130–137

2. Vallon-Christersson J, Cayanan C, Haraldsson K et al (2001) Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet 10(4):353–360

3. Williams RS, Chasman DI, Hau DD et al (2003) Detection of protein folding defects caused by BRCA1–BRCT truncation and missense mutations. J Biol Chem 278(52):53007–53016

4. Mazoyer S, Puget N, Perrin-Vidoz L et al (1998) A BRCA1 nonsense mutation causes exon skipping. Am J Hum Genet 62(3):713–715

5. Rodriguez JA, Au WW, Henderson BR (2004) Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain. Exp Cell Res 293(1):14–21

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of BRCA1/2 in hereditary and familial breast and ovarian cancers;Molecular Genetics & Genomic Medicine;2019-07-17

2. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer;Cancer Research;2017-03-10

3. In vitro prediction of breast cancer therapy toxicity;Annals of Translational Medicine;2017-03

4. BRCA1 mRNA levels following a 4–6-week intervention with oral 3,3′-diindolylmethane;British Journal of Cancer;2014-07-15

5. RAD21 Mutations Cause a Human Cohesinopathy;The American Journal of Human Genetics;2012-06